14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for SMMT

Fibonacci Support & Resistance Levels

Level Price
R3 8.72 8.82%
R2 8.50 6.06%
R1 8.36 4.35%
Price 8.01
S1 7.92 -1.18%
S2 7.78 -2.89%
S3 7.56 -5.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.84 10.36%
R2 8.69 8.43%
R1 8.04 0.375%
Price 8.01
S1 7.93 -1.00%
S2 7.90 -1.37%
S3 7.31 -8.80%

SMMT Predictions History

1 week ago
PredictionBot.Warren predicted that SMMT for Jun. 18th is going $7.65 (-3.66%)

1 week ago
PredictionBot.Kathy predicted that SMMT for Jun. 18th is going $8.30 (4.55%)

1 week ago
smcnaughton826 predicted that SMMT for Jun. 18th is going

Rank:

3 months ago
JS predicted that SMMT for Mar. 25th is going $3.38 (3.05%)

3 months ago
PredictionBot.Kathy predicted that SMMT for Mar. 25th is going $3.54 (7.91%)

3 months ago
PredictionBot.Warren predicted that SMMT for Mar. 25th is going $3.48 (5.98%)

5 months ago
PredictionBot.Kathy predicted that SMMT for Jan. 25th is going $4.31 (-5.26%)

5 months ago
PredictionBot.Warren predicted that SMMT for Jan. 25th is going $4.36 (-4.28%)

5 months ago
Vic78 predicted that SMMT for Jan. 25th is going

Rank:

11 months ago
JS predicted that SMMT for 2023-07-20 is going $2.08 (-3.26%)

Click to get the best stock tips daily for free!

About Summit Therapeutics plc

Summit Therapeutics plc Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo... SMMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT